Financial statements Cryos Terapia
Balance sheet data of CRYOS TERAPIA
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 393 897,63 | 513 473,44 | 1 464 242,06 |
| A. Fixed assets | 138 750,05 | 101 750,05 | 145 600,05 |
| B. Current assets | 255 147,58 | 411 723,39 | 1 318 642,01 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 393 897,63 | 513 473,44 | 1 464 242,06 |
| A. Equity | 155 811,49 | 157 032,32 | 161 635,49 |
| B. Liabilities and provisions for liabilities | 238 086,14 | 356 441,12 | 1 302 606,57 |
| I. Long-term liabilities | - | - | - |
| II. Short-term liabilities | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.